RadNet’s DeepHealth unveils at ECR 2026 portfolio of AI solutions

DeepHealth, a wholly owned subsidiary of RadNet (RDNT), unveils at ECR 2026 the industry’s portfolio of native clinical AI solutions and services across all core imaging modalities and spanning detection, assessment and monitoring, all on one platform. “As European nations scale their screening ambitions and confront rising workload pressures, our integrated portfoliois designedto stage shift disease, empower diagnostic excellence and expandpatientaccess, therebydrivingprecision care,” saidNiccolo Stefani,MD,Business Leader Population Health & Clinical AI,DeepHealth.”These solutions transform imaging pathways,enablinghealthcare systems to move from reactive treatment to proactive interventionwhile addressing the realities of diverse European markets,to improve patient outcomes.”